Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank67
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-35.31%
↑ 18% vs avg
Percentile
P67
Within normal range
Streak
2 yr
Consecutive growthDecelerating
Average
-42.94%
Historical baseline
PeriodValue
2025-35.31%
2024-36.83%
2023-42.46%
2022-34.44%
2021-116.01%
2020-35.51%
20190.00%